<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://new.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Fri, 10 Jul 2026 09:14:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://new.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Seegnal Announces Listing on the Frankfurt Stock Exchange</title>
   <link>http://www.streetinsider.com/Press+Releases/Seegnal+Announces+Listing+on+the+Frankfurt+Stock+Exchange/26755679.html</link>
   <description>
&lt;p&gt;CALGARY, AB, July  10, 2026  (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (&amp;quot;Seegnal&amp;quot; or the &amp;quot;Company&amp;quot;), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that its common shares will commence trading on the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse, &amp;quot;FSE&amp;quot;) today, July 10, 2026, under the ticker symbol &amp;quot;&lt;b&gt;2I1&lt;/b&gt;” (WKN: A41FV7).&lt;/p&gt;  &lt;p&gt;The Company&amp;apos;s common shares will continue to trade on the TSX Venture Exchange under the symbol &amp;quot;SEGN&amp;quot; (ISIN: CA81573E1060).&lt;/p&gt;  &lt;p&gt;The Frankfurt Stock Exchange is one of the world&amp;apos;s largest and most established trading venues by market capitalization and is operated by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Seegnal+Announces+Listing+on+the+Frankfurt+Stock+Exchange/26755679.html</guid>
   <pubDate>Fri, 10 Jul 2026 09:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56765791</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEGN</category>
   	  </item>
  <item>
   <title>Seegnal Announces Listing on the Frankfurt Stock Exchange</title>
   <link>http://www.streetinsider.com/Press+Releases/Seegnal+Announces+Listing+on+the+Frankfurt+Stock+Exchange/26755679.html</link>
   <description>
&lt;p&gt;CALGARY, AB, July  10, 2026  (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (&amp;quot;Seegnal&amp;quot; or the &amp;quot;Company&amp;quot;), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that its common shares will commence trading on the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse, &amp;quot;FSE&amp;quot;) today, July 10, 2026, under the ticker symbol &amp;quot;&lt;b&gt;2I1&lt;/b&gt;” (WKN: A41FV7).&lt;/p&gt;  &lt;p&gt;The Company&amp;apos;s common shares will continue to trade on the TSX Venture Exchange under the symbol &amp;quot;SEGN&amp;quot; (ISIN: CA81573E1060).&lt;/p&gt;  &lt;p&gt;The Frankfurt Stock Exchange is one of the world&amp;apos;s largest and most established trading venues by market capitalization and is operated by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Seegnal+Announces+Listing+on+the+Frankfurt+Stock+Exchange/26755679.html</guid>
   <pubDate>Fri, 10 Jul 2026 09:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56765791</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEGN</category>
   	  </item>
  <item>
   <title>Seegnal Announces Listing on the Frankfurt Stock Exchange</title>
   <link>http://www.streetinsider.com/Press+Releases/Seegnal+Announces+Listing+on+the+Frankfurt+Stock+Exchange/26755679.html</link>
   <description>
&lt;p&gt;CALGARY, AB, July  10, 2026  (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (&amp;quot;Seegnal&amp;quot; or the &amp;quot;Company&amp;quot;), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that its common shares will commence trading on the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse, &amp;quot;FSE&amp;quot;) today, July 10, 2026, under the ticker symbol &amp;quot;&lt;b&gt;2I1&lt;/b&gt;” (WKN: A41FV7).&lt;/p&gt;  &lt;p&gt;The Company&amp;apos;s common shares will continue to trade on the TSX Venture Exchange under the symbol &amp;quot;SEGN&amp;quot; (ISIN: CA81573E1060).&lt;/p&gt;  &lt;p&gt;The Frankfurt Stock Exchange is one of the world&amp;apos;s largest and most established trading venues by market capitalization and is operated by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Seegnal+Announces+Listing+on+the+Frankfurt+Stock+Exchange/26755679.html</guid>
   <pubDate>Fri, 10 Jul 2026 09:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56765791</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEGN</category>
   	  </item>
  <item>
   <title>Seegnal Announces Listing on the Frankfurt Stock Exchange</title>
   <link>http://www.streetinsider.com/Press+Releases/Seegnal+Announces+Listing+on+the+Frankfurt+Stock+Exchange/26755679.html</link>
   <description>
&lt;p&gt;CALGARY, AB, July  10, 2026  (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (&amp;quot;Seegnal&amp;quot; or the &amp;quot;Company&amp;quot;), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that its common shares will commence trading on the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse, &amp;quot;FSE&amp;quot;) today, July 10, 2026, under the ticker symbol &amp;quot;&lt;b&gt;2I1&lt;/b&gt;” (WKN: A41FV7).&lt;/p&gt;  &lt;p&gt;The Company&amp;apos;s common shares will continue to trade on the TSX Venture Exchange under the symbol &amp;quot;SEGN&amp;quot; (ISIN: CA81573E1060).&lt;/p&gt;  &lt;p&gt;The Frankfurt Stock Exchange is one of the world&amp;apos;s largest and most established trading venues by market capitalization and is operated by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Seegnal+Announces+Listing+on+the+Frankfurt+Stock+Exchange/26755679.html</guid>
   <pubDate>Fri, 10 Jul 2026 09:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56765791</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEGN</category>
   	  </item>
  <item>
   <title>Seegnal Announces Listing on the Frankfurt Stock Exchange</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Seegnal+Announces+Listing+on+the+Frankfurt+Stock+Exchange/26755679.html</link>
   <description>
&lt;p&gt;CALGARY, AB, July  10, 2026  (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (&amp;quot;Seegnal&amp;quot; or the &amp;quot;Company&amp;quot;), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that its common shares will commence trading on the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse, &amp;quot;FSE&amp;quot;) today, July 10, 2026, under the ticker symbol &amp;quot;&lt;b&gt;2I1&lt;/b&gt;” (WKN: A41FV7).&lt;/p&gt;  &lt;p&gt;The Company&amp;apos;s common shares will continue to trade on the TSX Venture Exchange under the symbol &amp;quot;SEGN&amp;quot; (ISIN: CA81573E1060).&lt;/p&gt;  &lt;p&gt;The Frankfurt Stock Exchange is one of the world&amp;apos;s largest and most established trading venues by market capitalization and is operated by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Seegnal+Announces+Listing+on+the+Frankfurt+Stock+Exchange/26755679.html</guid>
   <pubDate>Fri, 10 Jul 2026 09:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56765791</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEGN</category>
   	  </item>
  <item>
   <title>Seegnal Announces Listing on the Frankfurt Stock Exchange</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Seegnal+Announces+Listing+on+the+Frankfurt+Stock+Exchange/26755679.html</link>
   <description>
&lt;p&gt;CALGARY, AB, July  10, 2026  (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (&amp;quot;Seegnal&amp;quot; or the &amp;quot;Company&amp;quot;), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that its common shares will commence trading on the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse, &amp;quot;FSE&amp;quot;) today, July 10, 2026, under the ticker symbol &amp;quot;&lt;b&gt;2I1&lt;/b&gt;” (WKN: A41FV7).&lt;/p&gt;  &lt;p&gt;The Company&amp;apos;s common shares will continue to trade on the TSX Venture Exchange under the symbol &amp;quot;SEGN&amp;quot; (ISIN: CA81573E1060).&lt;/p&gt;  &lt;p&gt;The Frankfurt Stock Exchange is one of the world&amp;apos;s largest and most established trading venues by market capitalization and is operated by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Seegnal+Announces+Listing+on+the+Frankfurt+Stock+Exchange/26755679.html</guid>
   <pubDate>Fri, 10 Jul 2026 09:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56765791</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEGN</category>
   	  </item>
  <item>
   <title>Seegnal Announces Listing on the Frankfurt Stock Exchange</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Seegnal+Announces+Listing+on+the+Frankfurt+Stock+Exchange/26755679.html</link>
   <description>
&lt;p&gt;CALGARY, AB, July  10, 2026  (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (&amp;quot;Seegnal&amp;quot; or the &amp;quot;Company&amp;quot;), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that its common shares will commence trading on the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse, &amp;quot;FSE&amp;quot;) today, July 10, 2026, under the ticker symbol &amp;quot;&lt;b&gt;2I1&lt;/b&gt;” (WKN: A41FV7).&lt;/p&gt;  &lt;p&gt;The Company&amp;apos;s common shares will continue to trade on the TSX Venture Exchange under the symbol &amp;quot;SEGN&amp;quot; (ISIN: CA81573E1060).&lt;/p&gt;  &lt;p&gt;The Frankfurt Stock Exchange is one of the world&amp;apos;s largest and most established trading venues by market capitalization and is operated by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Seegnal+Announces+Listing+on+the+Frankfurt+Stock+Exchange/26755679.html</guid>
   <pubDate>Fri, 10 Jul 2026 09:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56765791</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEGN</category>
   	  </item>
  <item>
   <title>Seegnal Announces Listing on the Frankfurt Stock Exchange</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Seegnal+Announces+Listing+on+the+Frankfurt+Stock+Exchange/26755679.html</link>
   <description>
&lt;p&gt;CALGARY, AB, July  10, 2026  (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (&amp;quot;Seegnal&amp;quot; or the &amp;quot;Company&amp;quot;), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that its common shares will commence trading on the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse, &amp;quot;FSE&amp;quot;) today, July 10, 2026, under the ticker symbol &amp;quot;&lt;b&gt;2I1&lt;/b&gt;” (WKN: A41FV7).&lt;/p&gt;  &lt;p&gt;The Company&amp;apos;s common shares will continue to trade on the TSX Venture Exchange under the symbol &amp;quot;SEGN&amp;quot; (ISIN: CA81573E1060).&lt;/p&gt;  &lt;p&gt;The Frankfurt Stock Exchange is one of the world&amp;apos;s largest and most established trading venues by market capitalization and is operated by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Seegnal+Announces+Listing+on+the+Frankfurt+Stock+Exchange/26755679.html</guid>
   <pubDate>Fri, 10 Jul 2026 09:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56765791</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEGN</category>
   	  </item>
  <item>
   <title>Seegnal to Deploy its Medication Safety Platform Across Nazareth Hospital EMMS, Expanding its Israeli Hospital Footprint</title>
   <link>http://www.streetinsider.com/Press+Releases/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</link>
   <description>
&lt;p&gt;CALGARY, AB, June  25, 2026  (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (“Seegnal” or the “Company”), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that its Israeli operating subsidiary, Seegnal eHealth Ltd., has signed an agreement (the “Agreement”) to deploy Seegnal’s clinical decision support platform across Nazareth Hospital EMMS (“Nazareth Hospital” or the “Hospital”), one of the oldest hospitals in northern Israel that has served the Galilee for more than 160 years.&lt;/p&gt;  &lt;p&gt;Under the Agreement, Seegnal’s platform will be integrated directly into Nazareth Hospital’s clinical workflows, supporting approximately 424 members of the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</guid>
   <pubDate>Thu, 25 Jun 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02701246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22152539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.25081293</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00044420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13803275</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13812324</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56765791</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEGN</category>
   	  </item>
  <item>
   <title>Seegnal to Deploy its Medication Safety Platform Across Nazareth Hospital EMMS, Expanding its Israeli Hospital Footprint</title>
   <link>http://www.streetinsider.com/Press+Releases/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</link>
   <description>
&lt;p&gt;CALGARY, AB, June  25, 2026  (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (“Seegnal” or the “Company”), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that its Israeli operating subsidiary, Seegnal eHealth Ltd., has signed an agreement (the “Agreement”) to deploy Seegnal’s clinical decision support platform across Nazareth Hospital EMMS (“Nazareth Hospital” or the “Hospital”), one of the oldest hospitals in northern Israel that has served the Galilee for more than 160 years.&lt;/p&gt;  &lt;p&gt;Under the Agreement, Seegnal’s platform will be integrated directly into Nazareth Hospital’s clinical workflows, supporting approximately 424 members of the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</guid>
   <pubDate>Thu, 25 Jun 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02701246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22152539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.25081293</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00044420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13803275</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13812324</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56765791</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEGN</category>
   	  </item>
  <item>
   <title>Seegnal to Deploy its Medication Safety Platform Across Nazareth Hospital EMMS, Expanding its Israeli Hospital Footprint</title>
   <link>http://www.streetinsider.com/Press+Releases/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</link>
   <description>
&lt;p&gt;CALGARY, AB, June  25, 2026  (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (“Seegnal” or the “Company”), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that its Israeli operating subsidiary, Seegnal eHealth Ltd., has signed an agreement (the “Agreement”) to deploy Seegnal’s clinical decision support platform across Nazareth Hospital EMMS (“Nazareth Hospital” or the “Hospital”), one of the oldest hospitals in northern Israel that has served the Galilee for more than 160 years.&lt;/p&gt;  &lt;p&gt;Under the Agreement, Seegnal’s platform will be integrated directly into Nazareth Hospital’s clinical workflows, supporting approximately 424 members of the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</guid>
   <pubDate>Thu, 25 Jun 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02701246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22152539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.25081293</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00044420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13803275</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13812324</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56765791</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEGN</category>
   	  </item>
  <item>
   <title>Seegnal to Deploy its Medication Safety Platform Across Nazareth Hospital EMMS, Expanding its Israeli Hospital Footprint</title>
   <link>http://www.streetinsider.com/Press+Releases/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</link>
   <description>
&lt;p&gt;CALGARY, AB, June  25, 2026  (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (“Seegnal” or the “Company”), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that its Israeli operating subsidiary, Seegnal eHealth Ltd., has signed an agreement (the “Agreement”) to deploy Seegnal’s clinical decision support platform across Nazareth Hospital EMMS (“Nazareth Hospital” or the “Hospital”), one of the oldest hospitals in northern Israel that has served the Galilee for more than 160 years.&lt;/p&gt;  &lt;p&gt;Under the Agreement, Seegnal’s platform will be integrated directly into Nazareth Hospital’s clinical workflows, supporting approximately 424 members of the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</guid>
   <pubDate>Thu, 25 Jun 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02701246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22152539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.25081293</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00044420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13803275</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13812324</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56765791</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEGN</category>
   	  </item>
  <item>
   <title>Seegnal to Deploy its Medication Safety Platform Across Nazareth Hospital EMMS, Expanding its Israeli Hospital Footprint</title>
   <link>http://www.streetinsider.com/Press+Releases/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</link>
   <description>
&lt;p&gt;CALGARY, AB, June  25, 2026  (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (“Seegnal” or the “Company”), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that its Israeli operating subsidiary, Seegnal eHealth Ltd., has signed an agreement (the “Agreement”) to deploy Seegnal’s clinical decision support platform across Nazareth Hospital EMMS (“Nazareth Hospital” or the “Hospital”), one of the oldest hospitals in northern Israel that has served the Galilee for more than 160 years.&lt;/p&gt;  &lt;p&gt;Under the Agreement, Seegnal’s platform will be integrated directly into Nazareth Hospital’s clinical workflows, supporting approximately 424 members of the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</guid>
   <pubDate>Thu, 25 Jun 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02701246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22152539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.25081293</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00044420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13803275</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13812324</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56765791</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEGN</category>
   	  </item>
  <item>
   <title>Seegnal to Deploy its Medication Safety Platform Across Nazareth Hospital EMMS, Expanding its Israeli Hospital Footprint</title>
   <link>http://www.streetinsider.com/Press+Releases/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</link>
   <description>
&lt;p&gt;CALGARY, AB, June  25, 2026  (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (“Seegnal” or the “Company”), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that its Israeli operating subsidiary, Seegnal eHealth Ltd., has signed an agreement (the “Agreement”) to deploy Seegnal’s clinical decision support platform across Nazareth Hospital EMMS (“Nazareth Hospital” or the “Hospital”), one of the oldest hospitals in northern Israel that has served the Galilee for more than 160 years.&lt;/p&gt;  &lt;p&gt;Under the Agreement, Seegnal’s platform will be integrated directly into Nazareth Hospital’s clinical workflows, supporting approximately 424 members of the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</guid>
   <pubDate>Thu, 25 Jun 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02701246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22152539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.25081293</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00044420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13803275</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13812324</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56765791</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEGN</category>
   	  </item>
  <item>
   <title>Seegnal to Deploy its Medication Safety Platform Across Nazareth Hospital EMMS, Expanding its Israeli Hospital Footprint</title>
   <link>http://www.streetinsider.com/Press+Releases/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</link>
   <description>
&lt;p&gt;CALGARY, AB, June  25, 2026  (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (“Seegnal” or the “Company”), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that its Israeli operating subsidiary, Seegnal eHealth Ltd., has signed an agreement (the “Agreement”) to deploy Seegnal’s clinical decision support platform across Nazareth Hospital EMMS (“Nazareth Hospital” or the “Hospital”), one of the oldest hospitals in northern Israel that has served the Galilee for more than 160 years.&lt;/p&gt;  &lt;p&gt;Under the Agreement, Seegnal’s platform will be integrated directly into Nazareth Hospital’s clinical workflows, supporting approximately 424 members of the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</guid>
   <pubDate>Thu, 25 Jun 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02701246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22152539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.25081293</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00044420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13803275</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13812324</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56765791</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEGN</category>
   	  </item>
  <item>
   <title>Seegnal to Deploy its Medication Safety Platform Across Nazareth Hospital EMMS, Expanding its Israeli Hospital Footprint</title>
   <link>http://www.streetinsider.com/Press+Releases/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</link>
   <description>
&lt;p&gt;CALGARY, AB, June  25, 2026  (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (“Seegnal” or the “Company”), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that its Israeli operating subsidiary, Seegnal eHealth Ltd., has signed an agreement (the “Agreement”) to deploy Seegnal’s clinical decision support platform across Nazareth Hospital EMMS (“Nazareth Hospital” or the “Hospital”), one of the oldest hospitals in northern Israel that has served the Galilee for more than 160 years.&lt;/p&gt;  &lt;p&gt;Under the Agreement, Seegnal’s platform will be integrated directly into Nazareth Hospital’s clinical workflows, supporting approximately 424 members of the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</guid>
   <pubDate>Thu, 25 Jun 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02701246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22152539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.25081293</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00044420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13803275</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13812324</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56765791</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEGN</category>
   	  </item>
  <item>
   <title>Seegnal to Deploy its Medication Safety Platform Across Nazareth Hospital EMMS, Expanding its Israeli Hospital Footprint</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</link>
   <description>
&lt;p&gt;CALGARY, AB, June  25, 2026  (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (“Seegnal” or the “Company”), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that its Israeli operating subsidiary, Seegnal eHealth Ltd., has signed an agreement (the “Agreement”) to deploy Seegnal’s clinical decision support platform across Nazareth Hospital EMMS (“Nazareth Hospital” or the “Hospital”), one of the oldest hospitals in northern Israel that has served the Galilee for more than 160 years.&lt;/p&gt;  &lt;p&gt;Under the Agreement, Seegnal’s platform will be integrated directly into Nazareth Hospital’s clinical workflows, supporting approximately 424 members of the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</guid>
   <pubDate>Thu, 25 Jun 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02701246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22152539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.25081293</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00044420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13803275</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13812324</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56765791</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEGN</category>
   	  </item>
  <item>
   <title>Seegnal to Deploy its Medication Safety Platform Across Nazareth Hospital EMMS, Expanding its Israeli Hospital Footprint</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</link>
   <description>
&lt;p&gt;CALGARY, AB, June  25, 2026  (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (“Seegnal” or the “Company”), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that its Israeli operating subsidiary, Seegnal eHealth Ltd., has signed an agreement (the “Agreement”) to deploy Seegnal’s clinical decision support platform across Nazareth Hospital EMMS (“Nazareth Hospital” or the “Hospital”), one of the oldest hospitals in northern Israel that has served the Galilee for more than 160 years.&lt;/p&gt;  &lt;p&gt;Under the Agreement, Seegnal’s platform will be integrated directly into Nazareth Hospital’s clinical workflows, supporting approximately 424 members of the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</guid>
   <pubDate>Thu, 25 Jun 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02701246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22152539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.25081293</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00044420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13803275</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13812324</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56765791</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEGN</category>
   	  </item>
  <item>
   <title>Seegnal to Deploy its Medication Safety Platform Across Nazareth Hospital EMMS, Expanding its Israeli Hospital Footprint</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</link>
   <description>
&lt;p&gt;CALGARY, AB, June  25, 2026  (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (“Seegnal” or the “Company”), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that its Israeli operating subsidiary, Seegnal eHealth Ltd., has signed an agreement (the “Agreement”) to deploy Seegnal’s clinical decision support platform across Nazareth Hospital EMMS (“Nazareth Hospital” or the “Hospital”), one of the oldest hospitals in northern Israel that has served the Galilee for more than 160 years.&lt;/p&gt;  &lt;p&gt;Under the Agreement, Seegnal’s platform will be integrated directly into Nazareth Hospital’s clinical workflows, supporting approximately 424 members of the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</guid>
   <pubDate>Thu, 25 Jun 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02701246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22152539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.25081293</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00044420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13803275</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13812324</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56765791</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEGN</category>
   	  </item>
  <item>
   <title>Seegnal to Deploy its Medication Safety Platform Across Nazareth Hospital EMMS, Expanding its Israeli Hospital Footprint</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</link>
   <description>
&lt;p&gt;CALGARY, AB, June  25, 2026  (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (“Seegnal” or the “Company”), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that its Israeli operating subsidiary, Seegnal eHealth Ltd., has signed an agreement (the “Agreement”) to deploy Seegnal’s clinical decision support platform across Nazareth Hospital EMMS (“Nazareth Hospital” or the “Hospital”), one of the oldest hospitals in northern Israel that has served the Galilee for more than 160 years.&lt;/p&gt;  &lt;p&gt;Under the Agreement, Seegnal’s platform will be integrated directly into Nazareth Hospital’s clinical workflows, supporting approximately 424 members of the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</guid>
   <pubDate>Thu, 25 Jun 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02701246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22152539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.25081293</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00044420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13803275</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13812324</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56765791</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEGN</category>
   	  </item>
  <item>
   <title>Seegnal to Deploy its Medication Safety Platform Across Nazareth Hospital EMMS, Expanding its Israeli Hospital Footprint</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</link>
   <description>
&lt;p&gt;CALGARY, AB, June  25, 2026  (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (“Seegnal” or the “Company”), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that its Israeli operating subsidiary, Seegnal eHealth Ltd., has signed an agreement (the “Agreement”) to deploy Seegnal’s clinical decision support platform across Nazareth Hospital EMMS (“Nazareth Hospital” or the “Hospital”), one of the oldest hospitals in northern Israel that has served the Galilee for more than 160 years.&lt;/p&gt;  &lt;p&gt;Under the Agreement, Seegnal’s platform will be integrated directly into Nazareth Hospital’s clinical workflows, supporting approximately 424 members of the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</guid>
   <pubDate>Thu, 25 Jun 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02701246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22152539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.25081293</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00044420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13803275</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13812324</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56765791</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEGN</category>
   	  </item>
  <item>
   <title>Seegnal to Deploy its Medication Safety Platform Across Nazareth Hospital EMMS, Expanding its Israeli Hospital Footprint</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</link>
   <description>
&lt;p&gt;CALGARY, AB, June  25, 2026  (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (“Seegnal” or the “Company”), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that its Israeli operating subsidiary, Seegnal eHealth Ltd., has signed an agreement (the “Agreement”) to deploy Seegnal’s clinical decision support platform across Nazareth Hospital EMMS (“Nazareth Hospital” or the “Hospital”), one of the oldest hospitals in northern Israel that has served the Galilee for more than 160 years.&lt;/p&gt;  &lt;p&gt;Under the Agreement, Seegnal’s platform will be integrated directly into Nazareth Hospital’s clinical workflows, supporting approximately 424 members of the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</guid>
   <pubDate>Thu, 25 Jun 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02701246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22152539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.25081293</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00044420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13803275</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13812324</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56765791</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEGN</category>
   	  </item>
  <item>
   <title>Seegnal to Deploy its Medication Safety Platform Across Nazareth Hospital EMMS, Expanding its Israeli Hospital Footprint</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</link>
   <description>
&lt;p&gt;CALGARY, AB, June  25, 2026  (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (“Seegnal” or the “Company”), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that its Israeli operating subsidiary, Seegnal eHealth Ltd., has signed an agreement (the “Agreement”) to deploy Seegnal’s clinical decision support platform across Nazareth Hospital EMMS (“Nazareth Hospital” or the “Hospital”), one of the oldest hospitals in northern Israel that has served the Galilee for more than 160 years.&lt;/p&gt;  &lt;p&gt;Under the Agreement, Seegnal’s platform will be integrated directly into Nazareth Hospital’s clinical workflows, supporting approximately 424 members of the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</guid>
   <pubDate>Thu, 25 Jun 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02701246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22152539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.25081293</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00044420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13803275</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13812324</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56765791</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEGN</category>
   	  </item>
  <item>
   <title>Seegnal to Deploy its Medication Safety Platform Across Nazareth Hospital EMMS, Expanding its Israeli Hospital Footprint</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</link>
   <description>
&lt;p&gt;CALGARY, AB, June  25, 2026  (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (“Seegnal” or the “Company”), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that its Israeli operating subsidiary, Seegnal eHealth Ltd., has signed an agreement (the “Agreement”) to deploy Seegnal’s clinical decision support platform across Nazareth Hospital EMMS (“Nazareth Hospital” or the “Hospital”), one of the oldest hospitals in northern Israel that has served the Galilee for more than 160 years.&lt;/p&gt;  &lt;p&gt;Under the Agreement, Seegnal’s platform will be integrated directly into Nazareth Hospital’s clinical workflows, supporting approximately 424 members of the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Seegnal+to+Deploy+its+Medication+Safety+Platform+Across+Nazareth+Hospital+EMMS%2C+Expanding+its+Israeli+Hospital+Footprint/26688812.html</guid>
   <pubDate>Thu, 25 Jun 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02701246</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22152539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.25081293</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00044420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13803275</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13812324</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56765791</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEGN</category>
   	  </item>
  <item>
   <title>Seegnal Successfully Initiates First U.S. Pilot Program</title>
   <link>http://www.streetinsider.com/Press+Releases/Seegnal+Successfully+Initiates+First+U.S.+Pilot+Program/26668121.html</link>
   <description>
&lt;p&gt;CALGARY, AB, June  19, 2026  (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (&amp;quot;Seegnal&amp;quot; or the &amp;quot;Company&amp;quot;), a developer of innovative healthcare technology focused on mitigating medication risks, is pleased to announce that it  has successfully initiated its first pilot program in the U.S., following the letter of intent, announced on May 19, 2026.&lt;/p&gt;  &lt;p&gt;The pilot program is being conducted with a U.S.-based long-term care provider and is expected to run between 8 and 12 weeks from the receipt of data, followed by a potential extended evaluation period.&lt;/p&gt;  &lt;p&gt;Approximately 1.2 million Americans live in CMS-certified nursing facilities,1</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Seegnal+Successfully+Initiates+First+U.S.+Pilot+Program/26668121.html</guid>
   <pubDate>Fri, 19 Jun 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.56765791</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SEGN</category>
   	  </item>
 </channel>
</rss>
